Application 202814

Type
NDA
Sponsor
CIPLA LIMITED

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001LAMIVUDINE; ZIDOVUDINELAMIVUDINE; ZIDOVUDINETABLET, FOR SUSPENSION; ORAL30MG; 60MGNoNo

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
32318ORIG2012-06-18